{
    "Trade/Device Name(s)": [
        "ID NOW Instrument",
        "ID NOW Influenza A & B 2",
        "ID NOW Strep A 2",
        "ID NOW Flu 2",
        "Alere i Flu 2",
        "Alere i Influenza A & B 2",
        "ID NOW Strep 2",
        "Alere i Strep A 2"
    ],
    "Submitter Information": "Abbott Diagnostics Scarborough, Inc.",
    "510(k) Number": "K220801",
    "Predicate Device Reference 510(k) Number(s)": [
        "K171792",
        "K173653"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC",
        "OZE",
        "OOI",
        "PGX"
    ],
    "Summary Letter Date": "March 16, 2022",
    "Summary Letter Received Date": "March 18, 2022",
    "Submission Date": "March 16, 2022",
    "Regulation Number(s)": [
        "21 CFR 866.3980",
        "21 CFR 866.2680",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Respiratory Viral Panel Multiplex Nucleic Acid Assay",
        "Streptococcus spp Nucleic Acid-Based Assay",
        "Instrumentation for Clinical Multiplex Test Systems"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Influenza A viral RNA",
        "Influenza B viral RNA",
        "Streptococcus pyogenes (Group A Streptococcus) nucleic acid"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab",
        "Nasal or nasopharyngeal swabs eluted in viral transport media",
        "Throat swab"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ID NOW Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Isothermal nucleic acid amplification"
    ],
    "Methodologies": [
        "Qualitative detection",
        "Isothermal amplification"
    ],
    "Submission Type(s)": [
        "Instrument",
        "Assay",
        "Software",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Abbott ID NOW Instrument with Influenza A & B 2 and Strep A 2 assays using isothermal nucleic acid amplification for rapid detection of influenza A/B viral RNA and Group A Streptococcus nucleic acid.",
    "Indications for Use Summary": "Qualitative detection and differentiation of influenza A and B viral RNA from nasal or nasopharyngeal swabs and rapid detection of Group A Streptococcus (Streptococcus pyogenes) from throat swab specimens in patients with signs and symptoms of respiratory infection or pharyngitis.",
    "fda_folder": "Microbiology"
}